Debiopharm International SA

Debiopharm International SA

Debiopharm International SA

Overview
Date Founded

1979

Headquarters

5-7, chemin Messidor,Lausanne, Vaud 1002

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

Website

http://www.debiopharm.com

In The News
PR Newswire
January 9, 2020
Novadiscovery Raises Series A Financing to Scale its in silico Clinical Trial Platform - Debiopharm Leads the Round With EUR 5 Million; - Novadiscovery pioneers the use of in silico clinical trials to predict drug efficacy and optimize clinical developmen
PR Newswire
January 8, 2020
Knight Partners With Debiopharm for the Commercialization of Trelstar® in Canada
PR Newswire
September 30, 2019
Debiopharm's Novel IAP Antagonist Debio 1143 Achieves Outstanding Phase II Results for High-Risk Head and Neck Cancer Patients; Late breaking abstract results presented today at ESMO with chemo-radio sensitizer Debio 1143 present a promising breakthrough
PR Newswire
September 9, 2019
BC Platforms Provides Complete Data Management Solution for Debiopharm's Oncology Development Portfolio
PR Newswire
June 14, 2019
Global Antibiotic Resistance Markets, 2019-2023 - Examine the 6 Key Large Opportunities in this Space and Developed Market Forecasts

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Bertrand Ducrey

Chief Executive Officer

Vanessa Currat

General Counsel

Frédéric Lévy

Director, Head of Search & Evaluation & Scientific Innovation

Stéphane Bernard

Director, Project Management Office

Fabien Sebille

Director, Business Development, Licensing, Marketing & Communication

Peggy Lipp

Director, Regulatory Affairs, Business Intelligence & Market Access

Daniel Brandt

Director, Quality Management & Documentation

Manuela Perraudin

Director, Human Resources

Alexandre Maret

Director-Finance & Administration

Christine Deuschel Cornioley

Senior Vice President, Portfolio & Project Management

Trending People
Victorias Secret Direct, LLC
Bowing out Les - The Daily Telegraph (London)
Morgan Stanley
Biggest Wall Street bank deal since crash - The Daily Telegraph (London)
The Walt Disney Company
'The Clone Wars' kept the 'Stars Wars' flame alive; now it's streaming toward it... - CNN
Intel Corp.
Intel officials say Russia boosting Trump candidacy - Associated Press
Oracle Corp.
Some Oracle employees stop work in protest of Larry Ellison’s pro-Trump politics - Fortune
Trending Organizations
Victorias Secret Direct, LLC
Bowing out Les - The Daily Telegraph (London)
Morgan Stanley
Biggest Wall Street bank deal since crash - The Daily Telegraph (London)
The Walt Disney Company
'The Clone Wars' kept the 'Stars Wars' flame alive; now it's streaming toward it... - CNN
Intel Corp.
Intel officials say Russia boosting Trump candidacy - Associated Press
Oracle Corp.
Some Oracle employees stop work in protest of Larry Ellison’s pro-Trump politics - Fortune
Paths to Debiopharm International SA
Potential Connections via
Relationship Science
You
Debiopharm International SA
Recent Transactions
Details Hidden

Meridian Bioscience, Inc. purchases GenePOC, Inc. from Debiopharm International SA

Details Hidden

Debiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Transaction Advisors
Legal Advisor
Fasken Martineau DuMoulin LLP

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Legal Advisor
Gide Loyrette Nouel LLP

Advised onGecina purchases Eurosic SAS

Legal Advisor
E. Scott Conover

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Legal Advisor
Sylvie Bourdeau

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Attorney
Talia Markarian

Advised onDebiopharm International SA purchases Affinium Pharmaceuticals Ltd. from SV Health Investors LLP, Genesys Capital Partners, Inc., Forward Ventures Services LLC, Ontario Capital Growth Corp.

Investments
Details Hidden
GenePOC, Inc.

GenePOC, Inc. develops rapid molecular devices to detect genes at point-of-care. Its product includes an integrated portable instrument for the prevention and early detection of infectious diseases based on a centripetal technology platform. Its product also includes GenePOC disposable, a device for performing nucleic acid-based diagnostics at POC. The company's products are also used for infectious disease, rapid food microbiology, and human pharmacogenetic testing applications. The company was founded by Michel G. Bergeron in 2007 and is headquartered in Quebec, Canada.

Details Hidden
Diagnoplex SA

Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland.

Details Hidden
Agendia NV

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Suppliers
Immunogen Inc. Medical Support Services | WALTHAM, MA

ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.

Veeva Systems, Inc. Other Business & Consulting Services | PLEASANTON, CA

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Debiopharm International SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Debiopharm International SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Debiopharm International SA.